Stage 1: Seed Partnerships provides seed funding for new and established partnerships to conduct research that deepens understanding of the problem and sets the stage for testing solutions.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact is offering a Fall 2023 Seed Grant to support researchers and scientists in advancing specific domains of maternal-fetal science.
OCE supports campus units with one-time funding of up to $50K to deepen Stanford’s engagement locally and nationwide, with priority for projects working with marginalized communities in Santa Clara or San Mateo counties.
The King Center invites proposals from Stanford faculty and postdoctoral scholars for small projects or for seed funding of projects that have the potential to help the investigators to write competitive research proposals.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals for projects that use a recent advance in human organ modeling to address the IMA’s goals of accelerating the prototyping of innovative medicines and vaccines.
DUE: October 2nd The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
SCI’s mission is to translate Stanford discoveries into individualized cancer care and prevention. In keeping with its goal of educating and empowering the next generation of cancer researchers, SCI offers funding to cancer research fellows.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2023-24 Pilot and Feasibility (P&F) Program led by Drs. Anna Gloyn and Sun H Kim.
The Center for Artificial Intelligence in Medicine and Imaging (AIMI) and the Institute for Human-Centered Artificial Intelligence (HAI) jointly seek proposals that support new ideas that reimagine artificial intelligence in healthcare.
The goal of the Institute for Human-Centered Artificial Intelligence research program is to foster interdisciplinary AI research that aims to improve the human condition. We seek proposals for up to $75,000 that support new ambitious ideas.
The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs by offering funding, education and project-specific mentorship.
Grants up to $250k along with strategic and advisory support to accelerate the commercial delivery of Stanford-based innovations from across the University.
CTL offers quarterly teaching advancement grants of up to $2500 to Stanford instructors to support projects that directly enhance learning for Stanford students, with a particular emphasis on IDEAL goals.
C-ShARP (Community for Shared Advanced Research Platforms) invites new PIs to apply for Vouchers to be used in Stanford Shared Facilities. Vouchers will enable new PIs to navigate the facilities and to engage the staff of shared facilities.
Sanofi is awarding $150,000 funding for 1 year for translational research that can contribute to their early-stage pipeline and ultimately benefit patients. Please fill in the Pre-Proposal Submission Word Template before May 26th, 2023.
The Innovative Medicines Accelerator (IMA) is accepting proposals that address two major challenges in drug development: identifying drug leads and optimizing drug prototypes.
